Close
Biotech companies are leveraging artificial intelligence to salvage drugs that failed in clinical trials. With a staggering 90% of drugs not meeting their endpoints or facing safety concerns, AI offers a new avenue for repurposing these compounds. Companies like Ignota Labs and BioXcel Therapeutics are at the forefront, utilizing AI to address safety issues and enhance drug efficacy.
AI's role in drug development is transformative, allowing for rapid analysis of vast biomedical data to identify potential new uses for existing drugs. Ignota Labs focuses on resolving toxicity issues, while BioXcel Therapeutics aims to repurpose previously safe drugs for new therapeutic indications. This innovative approach not only saves time and resources but also holds the promise of delivering effective treatments to patients faster.
• AI helps repurpose failed drugs for new therapeutic uses.
• Ignota Labs addresses drug toxicity using AI technology.
AI is used to analyze biomedical data for drug repurposing and development.
Machine learning predicts drug interactions and potential new therapeutic targets.
Deep learning models are employed to understand drug safety issues and optimize drug design.
Ignota Labs uses AI to resolve toxicity issues in failed drugs and reintroduce them to trials.
BioXcel Therapeutics repurposes previously safe drugs for new indications, focusing on CNS disorders.
The Conversation on MSN.com 5month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
